1. Home
  2. VRCA vs ZVIA Comparison

VRCA vs ZVIA Comparison

Compare VRCA & ZVIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Verrica Pharmaceuticals Inc.

VRCA

Verrica Pharmaceuticals Inc.

HOLD

Current Price

$5.85

Market Cap

137.3M

Sector

Health Care

ML Signal

HOLD

Logo Zevia PBC

ZVIA

Zevia PBC

HOLD

Current Price

$1.52

Market Cap

111.3M

ML Signal

HOLD

Company Overview

Basic Information
Metric
VRCA
ZVIA
Founded
2013
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Beverages (Production/Distribution)
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
137.3M
111.3M
IPO Year
2018
2021

Fundamental Metrics

Financial Performance
Metric
VRCA
ZVIA
Price
$5.85
$1.52
Analyst Decision
Buy
Buy
Analyst Count
2
4
Target Price
$17.00
$4.93
AVG Volume (30 Days)
29.4K
1.1M
Earning Date
05-11-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
55.88
EPS
N/A
N/A
Revenue
$35,577,000.00
$161,259,000.00
Revenue This Year
N/A
$8.30
Revenue Next Year
$94.44
$6.87
P/E Ratio
N/A
N/A
Revenue Growth
370.22
4.01
52 Week Low
$0.52
$1.11
52 Week High
$9.82
$3.66

Technical Indicators

Market Signals
Indicator
VRCA
ZVIA
Relative Strength Index (RSI) 43.26 55.11
Support Level $5.32 $1.13
Resistance Level $6.48 $1.53
Average True Range (ATR) 0.48 0.12
MACD -0.01 -0.01
Stochastic Oscillator 8.33 69.74

Price Performance

Historical Comparison
VRCA
ZVIA

About VRCA Verrica Pharmaceuticals Inc.

Verrica Pharmaceuticals Inc is a therapeutics company developing and commercializing medications for the treatment of dermatologic diseases, including skin cancers. Its commercial product and portfolio of product candidates are clinician administered therapies in areas of high unmet need. This product portfolio consists of one product with an approved indication for molluscum contagiosum, or molluscum, with the potential for several follow-on indications, as well as additional pipeline product candidates. Its commercial product, YCANTH (VP-102), for the treatment of molluscum in adult and pediatric patients two years of age and older. YCANTH (VP-102) is a proprietary drug-device combination that contains a GMP-controlled formulation of cantharidin.

About ZVIA Zevia PBC

Zevia PBC is a beverage company disrupting the liquid refreshment beverage industry through refreshing, zero-calorie, zero-sugar, naturally sweetened beverages that are all Non-GMO Project Verified. It offers a platform of products that include a variety of flavors across Soda, Energy Drinks, Organic Tea, Mixers, Kidz drinks, and Sparkling Water. Its products are distributed across the U.S. and Canada through a network of retailers in the food, drug, mass, natural, and e-commerce channels. The company derives a majority of its revenue from the United States.

Share on Social Networks: